IC-776

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIC-776
Drug Alias NameIC-776
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-L/beta-2 (LFA-1) antagonists
TargetsIntegrin alpha-L/beta-2 (LFA-1)
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A